Flaviviruses-IN-3

CAS No. 420090-97-7

Flaviviruses-IN-3( —— )

Catalog No. M35977 CAS No. 420090-97-7

Flaviviruses-IN-3 (compound 87) is a potent inhibitor of flaviviruses, capable of reducing West Nile virus (WNV) protease activity by 54%.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 39 In Stock
5MG 39 In Stock
10MG 62 In Stock
25MG 125 In Stock
50MG 194 In Stock
100MG 271 In Stock
200MG 383 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Flaviviruses-IN-3
  • Note
    Research use only, not for human use.
  • Brief Description
    Flaviviruses-IN-3 (compound 87) is a potent inhibitor of flaviviruses, capable of reducing West Nile virus (WNV) protease activity by 54%.
  • Description
    Flaviviruses-IN-3 (compound 87) is a potent flaviviruse inhibitor. Flaviviruses-IN-3 reduces the WNV (West Nile virus) protease activity, with a inhibition of 54%.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Virus Protease
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    420090-97-7
  • Formula Weight
    473.54
  • Molecular Formula
    C26H23N3O4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (263.97 mM; Ultrasonic (<60°C)
  • SMILES
    CCc1ccc(cc1)-c1cc(C(=O)Nc2ccc(cc2)S(=O)(=O)NC(C)=O)c2ccccc2n1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Radhakrishnan Padmanabhan, et al. Flavivirus inhibitors and methods for their use. WO2010039538.
molnova catalog
related products
  • Sarmentosin

    Sarmentosin significantly lowers the SGPT level of patients suffering from chronic viral hepatitis, and shows a suppressive effect on cell-mediated immune responses in mice.

  • Astegolimab

    Astegolimab (RG 6149) is a humanised IgG2 monoclonal antibody that targets the IL-33 receptor and inhibits IL-33 signalling. Astegolimab is used in the study of chronic obstructive pulmonary disease (COPD) and severe asthma in adults.

  • Ceranib1

    Ceranib1 is an inhibitor of ceramidase. It inhibits the proliferation of ovarian cancer cells.